Streetbeat News

Analyst Ratings

EXR

Extra Space Storage (NYSE:EXR) has been evaluated by 7 financial analysts, with a mix of opinions ranging from bullish to indifferent. The average 12-month price target for EXR is $159.71, up 9.52% from the previous target of $145.83. Analysts from firms like Deutsche Bank, Goldman Sachs, Truist Securities, Morgan Stanley, Wells Fargo, and Stifel have adjusted their ratings and price targets, reflecting their views on the company's market position and financial performance. Extra Space Storage is a REIT with a strong market presence, significant revenue growth, high net margin, and effective asset utilization, but with a lower ROE than industry benchmarks.

Portfolio Pulse from Benzinga Insights

January 30, 2024 | 4:00 pm

KRP

Analysts have provided mixed reviews on Kimbell Royalty Partners (NYSE:KRP) over the past three months, with a recent negative shift in sentiment as the average 12-month price target was decreased by 4.25% to $20.75. The company faces challenges in revenue growth, net margin, ROE, and ROA, but has a sound debt-to-equity ratio. Analysts from Truist Securities, Raymond James, Keybanc, and Stifel have adjusted their ratings and price targets, reflecting their latest views on the company's performance and market conditions.

Portfolio Pulse from Benzinga Insights

January 30, 2024 | 4:00 pm

AMD

An in-depth analysis compares Advanced Micro Devices (AMD) to its competitors in the Semiconductors & Semiconductor Equipment industry. AMD's P/E ratio is significantly higher than the industry average, suggesting an overvalued stock. Its P/B ratio is below the industry average, indicating potential undervaluation by book value. The P/S ratio is also higher than the industry average, hinting at overvaluation by sales. AMD's ROE is below the industry average, suggesting inefficiency in profit generation from equity. The company's EBITDA and gross profit are below the industry average, indicating potential profitability challenges. AMD's revenue growth is lower than the industry average, pointing to a slower sales performance. AMD's lower debt-to-equity ratio compared to its top 4 peers suggests a stronger financial position with less reliance on debt financing.

Portfolio Pulse from Benzinga Insights

January 30, 2024 | 4:00 pm

PEPG

Wedbush analyst Laura Chico has reiterated an Outperform rating on PepGen (NASDAQ:PEPG) and maintained a price target of $21. This reaffirmation of the stock's potential could influence investor sentiment and the stock's short-term performance.

Portfolio Pulse from Benzinga Newsdesk

January 30, 2024 | 4:00 pm

F

GM

Ford Motor Co (NYSE:F) shares are trading higher, likely in response to General Motors Co's (NYSE:GM) strong quarterly results. GM reported Q4 revenue of $43 billion and adjusted earnings of $1.24 per share, surpassing estimates. GM's positive guidance for 2024 also contributed to its stock surge. Ford is expected to report its Q4 results on Feb. 6 with an anticipated EPS of 13 cents on $40.142 billion revenue. Analysts rate Ford as Neutral, and its stock has risen 17.47% over the past three months.

Portfolio Pulse from Adam Eckert

January 30, 2024 | 3:57 pm

SRPT

Wedbush analyst Andreas Argyrides has reiterated an Outperform rating on Sarepta Therapeutics (NASDAQ:SRPT) and maintained a price target of $224.

Portfolio Pulse from Benzinga Newsdesk

January 30, 2024 | 3:55 pm

INZY

Wedbush analyst David Nierengarten has reiterated an Outperform rating on Inozyme Pharma (NASDAQ:INZY) and maintained a $15 price target on the company's stock.

Portfolio Pulse from Benzinga Newsdesk

January 30, 2024 | 3:52 pm

NFLX

Netflix Inc (NASDAQ:NFLX) stock was downgraded from Buy to Neutral by Seaport Research Partners analyst David Joyce, who removed the price target. Joyce believes the stock is 'priced for perfection' and reflects the advertising opportunity. He notes Netflix's potential in advertising and gaming, positive FCF, and capital returns but sees the valuation metrics through 2027 as full. Joyce also mentions Netflix's move to acquire sports rights, which could affect margin expectations. NFLX shares declined by 1.9% to $564.43.

Portfolio Pulse from Priya Nigam

January 30, 2024 | 3:49 pm

RCUS

Wedbush analyst Robert Driscoll has maintained an Outperform rating on Arcus Biosciences (NYSE:RCUS) but reduced the price target from $36 to $30.

Portfolio Pulse from Benzinga Newsdesk

January 30, 2024 | 3:46 pm

PPBI

Wedbush analyst David Chiaverini has maintained a Neutral rating on Pacific Premier Bancorp (NASDAQ:PPBI) but has lowered the price target from $31 to $30.

Portfolio Pulse from Benzinga Newsdesk

January 30, 2024 | 3:38 pm